BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 29222693)

  • 1. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.
    Tomolonis JA; Agarwal S; Shohet JM
    Cell Tissue Res; 2018 May; 372(2):245-262. PubMed ID: 29222693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.
    Zage PE; Whittle SB; Shohet JM
    J Cell Biochem; 2017 Feb; 118(2):221-231. PubMed ID: 27428599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The embryonic trunk neural crest microenvironment regulates the plasticity and invasion of human neuroblastoma via TrkB signaling.
    Kasemeier-Kulesa JC; Spengler JA; Muolo CE; Morrison JA; Woolley TE; Schnell S; Kulesa PM
    Dev Biol; 2021 Dec; 480():78-90. PubMed ID: 34416224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking neural crest development to neuroblastoma pathology.
    Gonzalez Malagon SG; Liu KJ
    Development; 2022 Aug; 149(15):. PubMed ID: 35905010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
    Hsu DM; Agarwal S; Benham A; Coarfa C; Trahan DN; Chen Z; Stowers PN; Courtney AN; Lakoma A; Barbieri E; Metelitsa LS; Gunaratne P; Kim ES; Shohet JM
    Cancer Res; 2013 Jul; 73(13):4134-46. PubMed ID: 23687340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The connections between neural crest development and neuroblastoma.
    Jiang M; Stanke J; Lahti JM
    Curr Top Dev Biol; 2011; 94():77-127. PubMed ID: 21295685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural crest cells development and neuroblastoma progression: Role of Wnt signaling.
    Ahmad MH; Ghosh B; Rizvi MA; Ali M; Kaur L; Mondal AC
    J Cell Physiol; 2023 Feb; 238(2):306-328. PubMed ID: 36502519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma.
    Becker J; Wilting J
    Cell Mol Life Sci; 2018 Mar; 75(6):1057-1070. PubMed ID: 29058015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
    Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
    Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
    Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
    Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
    Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
    EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neuroblastoma stem cells.
    Ross RA; Spengler BA
    Semin Cancer Biol; 2007 Jun; 17(3):241-7. PubMed ID: 16839774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer.
    Wulf AM; Moreno MM; Paka C; Rampasekova A; Liu KJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
    Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
    Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on neuroblastoma.
    Newman EA; Abdessalam S; Aldrink JH; Austin M; Heaton TE; Bruny J; Ehrlich P; Dasgupta R; Baertschiger RM; Lautz TB; Rhee DS; Langham MR; Malek MM; Meyers RL; Nathan JD; Weil BR; Polites S; Madonna MB;
    J Pediatr Surg; 2019 Mar; 54(3):383-389. PubMed ID: 30305231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neuroblastoma I-type cells are malignant neural crest stem cells.
    Ross RA; Spengler BA; Domènech C; Porubcin M; Rettig WJ; Biedler JL
    Cell Growth Differ; 1995 Apr; 6(4):449-56. PubMed ID: 7794812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche.
    Pietras A; Gisselsson D; Ora I; Noguera R; Beckman S; Navarro S; Påhlman S
    J Pathol; 2008 Mar; 214(4):482-8. PubMed ID: 18189331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
    Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
    Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest.
    van Noesel MM
    Lancet Oncol; 2012 Mar; 13(3):229-30. PubMed ID: 22381931
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroblastoma: When differentiation goes awry.
    Zeineldin M; Patel AG; Dyer MA
    Neuron; 2022 Sep; 110(18):2916-2928. PubMed ID: 35985323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.